| by admin | No comments

When you’re sick and can’t take your medication, the NHS could save your life with a caromort heart surgery

It’s an operation that could save a life.

A surgeon has developed a device that uses ultrasound to deliver a pacemaker to the heart.

It’s a breakthrough that could be used to bypass heart attacks and help save people with heart problems.

The pacemaker is implanted inside the heart muscle.

When the surgeon presses on it, it triggers a heart muscle to contract and deliver a small electrical current.

This causes a tiny hole to form, called a caromed vent, which is filled with blood.

The device is implanted in the heart and a tube runs down the inside of the heart, through the heart’s main artery to the lower part of the body.

Once implanted, the caromed valve is attached to a machine that takes care of the pacemaker, sending an electrical signal through the blood vessels.

The device uses ultrasound waves to deliver an electrical current through the caromond valve and to deliver the pacemakers into the heart to deliver medication.

“The pacemaker is very strong and can deliver medication very quickly.

We think it could be very effective in patients who have had a pacemaking procedure but it’s not clear if this would work in other people,” said Dr David Jorgensen, a cardiologist at the University of Sydney and co-author of the study.

He said it would be a good idea for doctors to consider it if they’re unsure if the patient is at risk of having a heart attack.

“This technology could potentially be used in a very short time to reduce the risk of a person having a pacemeasurement procedure, such as a caromport heart procedure,” Dr Jorgenson said.

If the surgery was successful, it would potentially be the first time that the caromports heart had been used to treat a patient with a heart condition.

While it could take years to fully understand the technology, Dr Jogensen said it was the first step in a long journey towards a safer, more efficient pacemaker.

“We hope that we’ll have a clinical trial in a few years, with an implantation of the carommont valve in a patient, to see if it can reduce the incidence of heart attack,” he said.

“And hopefully we’ll get a better understanding of the mechanisms that allow it to work.”

Dr Jorgensens work was supported by the Australian Heart Foundation.